A trypsin Inhibitor from tamarind reduces food intake and improves inflammatory status in rats with metabolic syndrome regardless of weight loss

dc.contributor.authorMaciel, Bruna Leal Lima
dc.contributor.authorCarvalho, Fabiana Maria Coimbra de
dc.contributor.authorLima, Vanessa Cristina Oliveira de
dc.contributor.authorCosta, Izael de Souza
dc.contributor.authorMedeiros, Amanda Fernandes de
dc.contributor.authorSerquiz, Alexandre Coelho
dc.contributor.authorLima, Maíra Conceição Jerônimo de Souza
dc.contributor.authorSerquiz, Raphael Paschoal
dc.contributor.authorUchôa, Adriana Ferreira
dc.contributor.authorSantos, Elizeu Antunes dos
dc.contributor.authorMorais, Ana Heloneida de Araújo
dc.date.accessioned2024-02-27T19:20:57Z
dc.date.available2024-02-27T19:20:57Z
dc.date.issued2016-09
dc.description.resumoTrypsin inhibitors are studied in a variety of models for their anti-obesity and anti-inflammatory bioactive properties. Our group has previously demonstrated the satietogenic effect of tamarind seed trypsin inhibitors (TTI) in eutrophic mouse models and anti-inflammatory effects of other trypsin inhibitors. In this study, we evaluated TTI effect upon satiety, biochemical and inflammatory parameters in an experimental model of metabolic syndrome (MetS). Three groups of n = 5 male Wistar rats with obesity-based MetS received for 10 days one of the following: (1) Cafeteria diet; (2) Cafeteria diet + TTI (25 mg/kg); and (3) Standard diet. TTI reduced food intake in animals with MetS. Nevertheless, weight gain was not different between studied groups. Dyslipidemia parameters were not different with the use of TTI, only the group receiving standard diet showed lower very low density lipoprotein (VLDL) and triglycerides (TG) (Kruskal–Wallis, p < 0.05). Interleukin-6 (IL-6) production did not differ between groups. Interestingly, tumor necrosis factor-alpha (TNF-α) was lower in animals receiving TTI. Our results corroborate the satietogenic effect of TTI in a MetS model. Furthermore, we showed that TTI added to a cafeteria diet may decrease inflammation regardless of weight loss. This puts TTI as a candidate for studies to test its effectiveness as an adjuvant in MetS treatmentpt_BR
dc.identifier.citationCARVALHO, Fabiana Maria Coimbra de; LIMA, Vanessa Cristina Oliveira de; COSTA, Izael de Souza; MEDEIROS, Amanda Fernandes de; SERQUIZ, Alexandre Coelho; LIMA, Maíra Conceição Jerônimo de Souza; SERQUIZ, Raphael Paschoal; MACIEL, Bruna Leal Lima; UCHÔA, Adriana Ferreira; SANTOS, Elizeu Antunes dos; MORAIS, Ana Heloneida de Araújo. A trypsin Inhibitor from tamarind reduces food intake and improves inflammatory status in rats with metabolic syndrome regardless of weight loss. Nutrients, [S.l.], v. 8, n. 10, p. 544, 27 set. 2016. DOI: 10.3390/nu8100544. Disponível em: https://www.mdpi.com/2072-6643/8/10/544. Acesso em: 01 fev. 2024.pt_BR
dc.identifier.doihttp://dx.doi.org/10.3390/nu8100544
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/57689
dc.languageenpt_BR
dc.publisherNutrientspt_BR
dc.rightsAttribution 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.subjectObesitypt_BR
dc.subjectCafeteria dietpt_BR
dc.subjectTNF-αpt_BR
dc.subjectGlycemiapt_BR
dc.titleA trypsin Inhibitor from tamarind reduces food intake and improves inflammatory status in rats with metabolic syndrome regardless of weight losspt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
TrypsinInhibitor_Carvalho_2016.pdf
Tamanho:
763.28 KB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar